Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) Tax Provisions (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Tax Provisions for 15 consecutive years, with $3.3 million as the latest value for Q4 2024.

  • On a quarterly basis, Tax Provisions rose 15.45% to $3.3 million in Q4 2024 year-over-year; TTM through Dec 2024 was $13.3 million, a 41.81% increase, with the full-year FY2025 number at $15.1 million, up 13.92% from a year prior.
  • Tax Provisions was $3.3 million for Q4 2024 at Lemaitre Vascular, down from $3.4 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $3.7 million in Q2 2024 to a low of $1.7 million in Q4 2021.
  • A 5-year average of $2.5 million and a median of $2.2 million in 2021 define the central range for Tax Provisions.
  • Peak YoY movement for Tax Provisions: skyrocketed 164.16% in 2020, then dropped 5.71% in 2022.
  • Lemaitre Vascular's Tax Provisions stood at $1.9 million in 2020, then decreased by 7.24% to $1.7 million in 2021, then increased by 17.51% to $2.0 million in 2022, then soared by 40.09% to $2.8 million in 2023, then grew by 15.45% to $3.3 million in 2024.
  • Per Business Quant, the three most recent readings for LMAT's Tax Provisions are $3.3 million (Q4 2024), $3.4 million (Q3 2024), and $3.7 million (Q2 2024).